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Abstract  
Chrysophyllum albidum commonly called African star apple, has been reported for its antidiabetic potential but its 
effect on liver and kidney functions in diabetic rats has not been well investigated. This study investigated effects 
of Chrysophyllum albidum fruit-skin (CAFS) supplemented diet on Streptozotocin-induced diabetic rats. Diabetes 
was induced intraperitonealy at a single dose of 50mg/kg bw of Streptozotocin (STZ). Forty male Wistar rats 
weighing averagely 170g were randomly divided into four groups of ten rats each; Group 1-Normal control, Group 
2-Diabetic control, Group 3-Diabetic rats treated Glibenclamide, Group 4-Diabetic rats treated 70g/kg CAFS 
supplemented diet. After four weeks of treatment, the rats were sacrificed. Liver function biomarkers (Alanine 
aminotransferase (ALT), Aspartate aminotransferase (AST) and Alkaline phosphatase (ALP)) activities, kidney 
function biomarkers (Creatinine and Urea), electrolyte ions (K+,  Na+,  HCO3- and Cl-), total protein and bilirubin 
levels were measured in the plasma. The diabetic control exhibited hepato-renal dysfunction with significant 
(p<0.05) increase in the liver marker enzymes’ activities, total bilirubin, creatinine and urea concentrations while 
decreasing total protein, albumin and electrolyte ions levels compared with normal control group. Treatment with 
CAFS supplemented diet significantly (p<0.05) enhanced liver and kidney recovery by reducing the elevated 
activities of liver marker enzymes, reversed the increments in creatinine, urea and total bilirubin while increasing 
the concentration of total protein and restoring electrolyte ions concentrations to near normal values. CAFS 
supplemented diet has hepatic- and renal protective effects on STZ-induced diabetic rats. Thus, CAFS could be 
considered as therapeutic agent against the progression of diabetes complications. 
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1.0 Introduction 
Diabetes mellitus (DM) is a major global public health problem with an escalating incidence and prevalence, 
particularly in developing and newly industrialized countries (Danaei et al., 2011). Globally, in the year 2015, 415 
million people were estimated to have diabetes and by 2040, the prevalence is projected to increase to 642 million 
(International Diabetes Federation, 2015). One of the most important clinical features of diabetes is its associated 
complications, which can affect multiple vital organ systems, thereby leading to more severe and irreversible 
pathological conditions such as nephropathy, retinopathy, hepatopathy, vasculopathy, neuropathy and 
cardiovascular diseases (Reid, 2006). The duration and severity of hyperglycemia is the major causative factor in 
initiating organ damage. 
Researches indicate that, DM is associated with a number of liver abnormalities that affect glycogen and lipid 
metabolism (Sanchez  et al., 2000; Bolkent et al., 2004; Koyuturk et al., 2005). Our previous study demonstrated 
that persistent hyperglycemia caused significant reduction in the liver glycogen levels and elevation of plasma and 
hepatic lipids (except high-density lipoprotein (HDL)) contents in diabetic rats (Ibrahim et al., 2019b). Another 
studies by Chiang et al. (2011), Birkenfeld and Shulman (2014) as well as Nakahara et al. (2014) found that DM 
causes liver disease, such as hepatic steatosis, nonalcoholic steatohepatitis, fibrosis and cirrhosis. A fatty liver and 
hyperglycaemia candestroy the hepatocytes and contribute to increased morbidity and mortality among diabetic 
patients (Levinthal and Tavill, 1999).  
Kidney disease attributed to diabetes is a major but under-recognized contributor to the global burden of 
disease. As reported by Reutens (2013), United States Renal Data System Annual Data Report (2015) and 
Papadopoulou-Marketou et al. (2018), diabetic kidney disease (DKD) develops in approximately 30% of patients 
with type1 diabetes mellitus (DM1) and approximately 40% of patients with type 2 diabetes mellitus (DM2). Its 
increasing prevalence parallels the dramatic worldwide rise in prevalence of diabetes (De Boer et al., 2011, World 
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online)  
Vol.10, No.6, 2020 
 
8 
Health Organization, 2014) and is considered the single strongest predictor of mortality in patients with diabetes 
(Maisonneuve et al., 2000, United States Renal Data System, 2003). Development of DKD is associated with 
many alterations in the structure of multiple kidney compartments, which lead to glomerular hypertrophy, 
glomerulo sclerosis, tubulointerstitial inflammation and fibrosis. The most characteristic marker of DKD is 
albuminuria, which is associated with renal disease progression and cardiovascular events (Gross et al., 2005). 
The Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation 
trial showed that intensive glucose control could reduce development of microalbuminuria and macroalbuminuria 
(Perkovic et al., 2013). 
In recent times, attentions are being drawn to complementary and alternative treatments for diabetes focusing 
on functional foods and their bioactive compounds (Tahrani et al., 2010; Karigidi and Olaiya, 2019). 
Chrysophyllum albidum, commonly called African star apple is one of such functional foods, which belongs to 
Sapotaceae family and locally called ‘agbalumo’ in Yoruba,‘agwaluma’ in Hausa and ‘udara’ in Ibo tribes of 
Nigeria (Amusa et al.,2003; Bello and Henry, 2015). It is distributed in the tropical rain forest and coastal region 
of West Africa (Amusa et al., 2003). C. albidum fruit (Figure 1) is seasonal, found between December and April. 
Its fruit skin or peel is orange to golden yellow in colour when ripe and is chewy like gum with sweet/sour taste. 
The fruit-pulp has application in jams and jellies and can compete with raspberry jams and jellies (Okafor, 1975, 
Umelo, 1997).  
Figure 1: Chrysophyllum albidum fruits 
Source:  Orwa et al. (2009) 
Studies on different parts of C. albidum plant showed the antioxidants nature of the plant (Idowu et al., 2006; 
Okoli and Okere, 2010; Adebayo et al., 2011b; Imaga and Urua, 2013; Omotosho et al., 2013; Egharevba et al., 
2015), which can support health by scavenging free radicals and prevent oxidative stress related diseases (Burits 
and Bucar, 2002).Olorunnisola  et al. (2008) reported the hypolipidemic and hypoglycemic properties of C. 
albidum seed cotyledon and Adebayo et al. (2011a) demonstrated the hepatoprotective effect of C. albidum leaf 
extract against carbon tetrachloride (CCl4) induced liver damage in Wistar rats.  Previously, we reported the 
antioxidant effect of C. albidum fruit skin extracts that was associated with flavoniods and phenolic contents 
(Ibrahim et al., 2019a). In addition, the hypolipidemic and antihyperglycemic potentials of C. albidum fruit skin 
in STZ-induced diabetic rats was demonstrated (Ibrahim et al., 2019b). The aim of the present study was to explore 
the effect of C. albidum fruit skin supplementation on liver and kidney function parameters of STZ-induced 
diabetic rats. 
 
2.0Materials and methods  
2.1 Chemicals      
All chemicals and drug used were of analytical grade. Chemicals, drug and solvents were purchased from Sigma 
Chemical Co. (St Louis, MO, USA). Assay kits purchased from Randox Laboratories Limited, UK were used for 
the analysis of liver and renal function parameters. 
  
2.2 Collection and preparation of C. albidum fruit skin  
The C. albidum fruits were purchased in Moniya market, Akinyele local government area of Oyo State, South-
Western Nigeria and washed. The fruit skin was separated, cut into small pieces and lyophilized using Lyophilizer 
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Millorock Bench-Top Freeze Dryer, Germany. Lyophilized sample was stored at -20ºC until further use.  
 
2.3 Feed formulation 
Two diets were formulated according to the recommendations of National Academy of Sciences (1995) on 
nutrients requirement for laboratory rats for growth and maintenance as described in our previous study (Ibrahim 
et al., 2019b). Normal control (NC) diet, which is free of C. albidum fruit-skin (CAFS) and Test (CAFS) diet, 
which was supplemented with 70g/kg CAFS. The two feed formulations were made into pellets to appeal to the 
rats.  
 
2.4 Experimental animals 
Male Wistar rats weighing averagely 170g were obtained from the animal house of the Department of Physiology, 
Ben Carson (Snr) School of Medicine, Babcock University, Ilishan-Remo, Nigeria. Rats were fed with commercial 
pellets and water ad libitum during the two weeks of acclimatization under standard laboratory conditions. After  
induction of DM, they were treated with CAFS supplemented diet for four weeks. All experiments were conducted 
in compliance with ethical guide for care and use of laboratory animals of the Babcock University Health Research 
Ethics Committee (BUHREC). 
 
2.5 Induction of Diabetes Mellitus 
Diabetes was induced in overnight fasted rats by a single intraperitoneal injection of STZ (50 mg/kg bodyweight 
(bw)) dissolved in freshly prepared citrate buffer (0.1 M, pH 4.5). After 72 h of STZ administration, fasting blood 
glucose (FBG) levels were checked using an Accu-Chek glucometer and rats with FBG≥ 250 mg/dL were 
considered diabetic and used in the present study. 
 
2.6 Experimental design 
Forty (40) male Wistar rats were randomly divided into 4 groups of 10 rats each.  
Group 1: Non-diabetic rats, served as normal control group.  
Group 2: Diabetic untreated rats, served as diabetic control group.  
Group 3: Diabetic rats, received 2.5mg/kg bw glibenclamide as a standard drug in 1 ml normal saline orally by 
intragastric tube once in a day for four weeks, served as glibenclamide treated diabetic rats 
Group 4: Diabetic rats, fed with a 70g/kg freeze dried-Chrysopyllum albidum fruit skin (CAFS) supplemented diet, 
served as CAFS treated diabetic rats. 
In addition, rats in groups 1-3 were fed with the formulated NC diet (free of CAFS)  and groups 1, 2 & 4 received 
only 1 ml normal saline orally by intragastric tube once in a day for four weeks while given water ad libitum to all 
the groups.  
 
2.7 Blood collection and preparation of sample 
After the four weeks of experimental period, rats were sacrificed and blood sample was collected by cardiac 
puncture into lithium-heparinized bottles. It was centrifuged at 10,000 x g for 15 minutes to obtain the plasma, 
which was used for the analysis of liver and renal function parameters.  
 
2.8 Determination of liver and renal function parameters 
The liver function parameters and renal markers (Urea and creatinine) concentrations in the plasma were estimated 
using Randox assay Kits (Randox Laboratories Ltd, UK).The electrolyte ions (Na+, K+, Cl- and HCO3-) 
concentrations were estimated using ion selective electrode, ISE analyzer (Audicom AC9900 automatic electrolyte 
analyzer). The methods of Reitman and Frankel (1957) were employed to estimate aspartate aminotransferase 
(AST) and alanine aminotransferase (ALT) activities in the plasma. The procedure described by Kind and King 
(1954) was used to estimate alkaline phosphatase activities while the methods of Tietz (2012) were used to 
determine the total protein and direct bilirubin (conjugated bilirubin) contents of the sample. Total bilirubin was 
determined colorimetrically according to the method described by Jendrassik and Grof, (1938) while albumin was 
determined using the method described by Weichselbaum, (1946) and Henry, (1974). The procedure of Fawcett 
and Scott (1960) was used to determine urea concentration while creatinine concentration was determined by the 
method of Boneses and Taussk (1945).  
      Percentage (%) decrease was calculated using the formula:       
                        Diabetic Control (DC) __ Treatment (T)   ×   100                        (1)  
                                        Diabetic Control (DC) 
 
     Percentage (%) increase was calculated using the formula:   
                         Treatment (T) __   Diabetic Control (DC)  ×   100                       (2) 
Diabetic Control (DC)    
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2.9 Statistical analysis 
The obtained data was analyzed using standard Statistical Software Package for Social Sciences (SPSS) for 
Window XP Software Programme (version 13.0). Group comparisons were done using one way analysis of 
variance (ANOVA) test.  Significant differences between control groups and experimental groups were assessed 
by Least Significant Difference (LSD) to test the significance at p< 0.05. All data were expressed as Mean ± 
Standard error of the mean (SEM), n=6. 
 
3.0 Results  
3.1 Effect of CAFS on liver function parameters 
The protective effects of CAFS supplementation on liver function parameters in STZ-induced diabetic rats were 
shown in (Figures 2- 9).  It was observed that induction of diabetes significantly (p < 0.05) increased the activities 
of plasma AST (Figure 2) from 19.87±1.05 to 59.22±2.17U/L, ALT (Figure 3) from 18.70±0.97 to 28.49±2.31U/L, 
ALP (Figure 4) from 288.51±1.98 to 911.16±2.27 U/L and AST:ALT (Figure 5) from 1.06±0.003 to1.80±0.14 
compared to rats in the control group.  However, treatment of diabetic rats with both CAFS supplemented diet and 
glibenclamide (standard drug) resulted in the suppression of elevated activities of plasma AST by 52% in both 
CAFS and glibenclamide-treated rats and ALP by 59% and 52% in CAFS and glibenclamide-treated rats 
respectively while the elevated activity of ALT in the two treatment groups were mildly suppressed. Feeding of a 
70g/kg CAFS supplemented diet to diabetic rats for four weeks exhibited similar ameliorative effects with daily 
administration of 2.5mg/kg bw glibenclamide to diabetic rats for four week of treatment. 
 
 
 
Figure 2: Effect of CAF supplemented diet on AST activity of streptozotocin-induced diabetic rats. 
‘a’ is significantly different from normal  control at (p < 0.05), ‘b’ is significantly different from diabetic control  
at (p < 0.05). 
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Figure 3: Effect of CAF supplemented diet on ALT activity of streptozotocin-induced diabetic rats. 
‘a’ is significantly different from normal  control at (p < 0.05), ‘b’ is significantly different from diabetic control  
at (p < 0.05). 
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Figure 4: Effect of CAF supplemented diet on Alkaline phosphatase (ALP) of streptozotocin-induced diabetic 
rats. 
‘a’ is significantly different from normal  control at (p < 0.05), ‘b’ is significantly different from diabetic control  
at (p < 0.05). 
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Figure 5: Effect of CAF supplemented diet on AST: ALT ratio of streptozotocin-induced diabetic rats. 
‘a’ is significantly different from normal  control at (p< 0.05), ‘b’ is significantly different from diabetic control  
at (p < 0.05). 
Similar to the trend of liver marker enzymes, the total bilirubin (Figure 6) and unconjugated bilirubin (Figure 
7) levels were also significantly (p < 0.05) increased in diabetic untreated rats from 0.73±0.07 to 1.15±0.10mg/dl 
and 0.23± 0.04 to 0.82 ± 0.09mg/dl respectively compared to rats in the control group. However, the increment 
observed in both total - and unconjugated bilirubins were reversed by 32% & 63% in diabetic rats treated with 
CAFS supplemented diet and by 29% & 55% in diabetic rats treated with glibenclamide. In addition, the present 
study also showed that diabetes state significantly (p < 0.05) decrease the plasma levels of conjugated bilirubin 
from 0.50±0.04 mg/dl to 0.33±0.02 mg/dl  (Figure 6) and  total protein  from  8.95±0.09 g/dl  to 5.16±0.03g/dl 
(Figure 8). Treatment of diabetic rats with both CAFS supplemented diet and glibenclamide; however inhibited 
these suppressions by 45% and 36% respectively for conjugated bilirubin and 55% in the two treatments. 
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Figure 6: Effect of CAF supplemented diet on Total bilirubin of streptozotocin-induced diabetic rats. 
‘a’ is significantly different from normal control at (p < 0.05), ‘b’ is significantly different from diabetic control 
at (p < 0.05). 
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Figure 7: Effect of CAF supplemented diet on conjugated bilirubin of streptozotocin-induced diabetic rats. 
‘a’ is significantly different from normal  control at (p < 0.05), ‘b’ is significantly different from diabetic control  
at (p < 0.05). 
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Figure 8: Effect of CAF supplemented diet on unconjugated bilirubin of streptozotocin-induced diabetic rats.  
‘a’ is significantly different from normal  control at (p < 0.05), ‘b’ is significantly different from diabetic control  
at (p < 0.05). 
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Figure 9: Effect of CAF supplemented diet on Total protein of streptozotocin-induced diabetic rats.  
‘a’ is significantly different from normal  control at (p < 0.05), ‘b’ is significantly different from diabetic control  
at (p < 0.05). 
 
3.2 Effect of CAFS on Renal function parameters 
The changes in plasma concentration of Creatinine, Urea, Albumin, Globulin and Albumin: Globulin ratio of STZ-
induced diabetic rats fed with and without CAFS supplemented diet are presented in Figures 10-14. It was observed 
that induction of diabetes was associated with significant (p<0.05) increase in the plasma levels of 
creatinine(1.06±0.04mg/dl to 1.18 ± 0.01mg/dl; Figure 10) and urea (42.07±1.98mg/dl to 85.23 ± 3.03mg/dl; 
Figure 11). On the contrary, diabetes state resulted in decreased plasma levels of albumin (5.23±0.32g/dl to 
1.91±0.16g/dl; Figure 12), Globulin (3.71 ± 0.30g/dl to 3.24 ± 0.17g/dl; Figure 13) and Albumin: Globulin ratio 
(1.48 ± 0.20 to 0.60± 0.07; Figure 14) relative to rats in the control group. Treatment of diabetic rats with both 
CAFS supplemented diet and glibenclamide for four weeks  however, reversed the elevations in creatinine by 8% 
and 10% respectively and in urea by 35% in the two treatments while albumin, globulin and Albumin: Globulin 
ratio were restored significantly (p < 0.05) to near normal values. 
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Figure 10: Effect of CAF supplemented diet on Creatinine concentration of streptozotocin-induced diabetic rats. 
‘a’ is significantly different from normal  control at (p < 0.05), ‘b’ is significantly different from diabetic control  
at (p < 0.05). 
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Figure 11: Effect of CAF supplemented diet on Urea concentration of streptozotocin-induced diabetic rats. 
‘a’ is significantly different from normal  control at (p < 0.05), ‘b’ is significantly different from diabetic control  
at (p < 0.05). 
0
2
4
6
NORMAL CONTROL
DIABETIC CONTROL
GLIBENCLAMIDE
CAFS
a
ab ab
A
lb
u
m
in
 (
g
/d
l)
 
Figure 12: Effect of CAF supplemented diet on Albumin concentration of streptozotocin-induced diabetic rats. 
‘a’ is significantly different from normal  control at (p < 0.05), ‘b’ is significantly different from diabetic control  
at (p < 0.05). 
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Figure 13: Effect of CAF supplemented diet on Globulin concentration of streptozotocin-induced diabetic rats. 
‘a’ is significantly different from normal  control at (p < 0.05), ‘b’ is significantly different from diabetic control  
at (p < 0.05). 
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Figure 14: Effect of CAF supplemented diet on Albumin: Globulin ratio of streptozotocin-induced diabetic rats. 
‘a’ is significantly different from normal  control at (p < 0.05), ‘b’ is significantly different from diabetic control  
at (p < 0.05). 
As depicted in Table1, the present study on electrolyte ions concentrations showed that diabetic rats exhibited 
significant (p < 0.05) reduction in plasma K+, Na+ and HCO3- while increasing the plasma Cl- compared to rats in 
the control group. Treatment of diabetic rats with both CAFS supplemented diet and glibenclamide however, 
produced significant (p < 0.05) restorative effects on the altered electrolyte ions concentrations by effecting 
normalcy in the concentrations. 
Table 1: Effects of CAFS on plasma electrolyte ions concentrations (mmol/L) of STZ-induced diabetic rats 
Parameters  Normal Control  Diabetic Control Glibenclamide CAFS 
Potassium (K+) 4.61 ± 0.09 3.76 ± 0.20a 4.69 ± 0.14b 4.88 ± 0.27b 
Sodium (Na+) 136.78 ± 1.47 111.52 ± 1.24a 139.85 ± 0.68b 138.71 ± 1.27b 
Chloride (Cl-) 138.07 ± 0.78 151.57 ± 1.28a 138.45 ± 1.15b 139.80 ± 2.49b 
Bicarbonate 
(HCO3-) 
24.14 ± 1.09 19.20 ± 1.15a 24.00 ± 1.26b 24.22 ± 0.65b 
Values are expressed as mean± SEM, n= 6. ‘a’ represents significant different from normal  control at (p < 0.05), 
‘b’ represents significant different from diabetic control  at (p < 0.05). 
 
Discussion 
The liver and kidney function  parameters  are useful ‘biomarkers’ for assessment of tissues damages and 
measurement of activities of various enzymes in the tissues and body fluids and thus,  play significant roles in 
disease investigation and diagnosis (Malomo, 2000). In this study, we observed alterations in the levels of liver 
and kidney function parameters in STZ-induced diabetic rats and these following the treatment with CAFS 
supplementation four weeks, these alterations were reversed. Diabetic rats in this study showed elevation of liver 
maker enzymes (ALT, AST and ALP) activities in the plasma and corroborates those of other authors who also 
reported increased ALT, AST and ALP activities in STZ-induced diabetic rats (Saeed et al., 2008; Zheng et al., 
2010 and Abdel-Moneim et al., 2016). Patients with type 2 diabetes have higher incidence of liver function 
abnormalities compared to normal individuals (Agarawal, 2015, Ghimire et al., 2018). ALT is a cytoplasmic 
enzyme found in very high concentration in the liver where it plays a vital role in the metabolism of amino acid 
(Whitehead et al., 1999). However, during liver assault or damage, ALT leaked from the hepatocytes into the 
blood circulation and become elevated (Whitehead et al., 1999, Elizabeth and Harris, 2005). This is usually 
accompanied by a rise in AST activity (Adebayo et al., 2010). ALP is found predominantly in the bile duct of the 
liver and is an indicator of biliary function, cholestasis and hepatic function (Whitehead et al., 1999, Elizabeth and 
Harris, 2005).  An increase in the activities of AST, ALT and ALP in plasma of diabetic untreated rats could be 
attributed to the leakage of these enzymes from the liver cytosol into blood stream, giving an indication of hepatic 
injury and loss of functional integrity (Mirmohammadlu et al., 2015). In diabetes, liver injury may occur because 
of deleterious effect of hyperglycemia through the inhibition of complex III, generation of reactive oxygen species 
(ROS) and a change in membrane permeability (Harrison, 2006; Hickman and Macdonald, 2007).  This may have 
a consequential effect on the metabolism and regulation of amino acids in the liver. 
The present study showed restoration of elevated levels of AST, ALT and ALP in plasma of diabetic rats 
treated with CAFS supplementation. Adebayo et al. (2011a) reported similar effects on diabetic animals treated 
with C. albidum leaf extracts against CCl4-induced liver damage. Some phytochemicals such as flavonoids, 
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triterpenoids, saponins and alkaloids have been linked with hepatic protection. The phytochemical investigation 
on C. albidum fruit skin also showed the presence of flavonoids, phenols, tannins and alkaloids (Ibrahim et al., 
2017), suggesting the hepatoprotective role of CAFS against liver injury associated with diabetes. This 
hepatoprotective property may be due to individual or combined effects of the active secondary metabolites present 
in CAFS supplemented diet. However, the exact phytochemical (active secondary metabolite) responsible for the 
hepatoprotective property needs further investigation. The prevention of alteration in the activities of ALT, AST 
and ALP towards their normal levels may be ascribed to the regeneration of hepatic cells by the active 
phytochemicals (Ahmad et al., 2000) with hepatoprotective effects in CAFS. This suggests that CAFS may 
possibly stabilize the plasma membrane and ameliorates hepatic tissue damage (Effiong and Akpan, 2015). Similar 
to the above trend was the observed changes in plasma AST:ALT ratio. STZ-induced diabetic rats showed an 
increase in AST: ALT ratio compared to normal control rats. The ratio of AST to ALT has been reported to be a 
marker of non-alcoholic liver damage occasioned by diabetes or obesity (Shreevastva et al., 2017). Treatment with 
both CAFS and glibenclamide in the present study however, suppressed these alterations by bringing the values 
close to the normal values. This result is consistent with the studies of David-Oku et al. (2013), who reported a 
non-dose dependent decrease in AST/ALT ratio of diabetic rats treated with Gongronema latifolium crude leaf 
extract. The present study also agrees with the studies of Shreevastva et al. (2017), who reported AST: ALT ratio 
of less than 2 in most non-alcoholic liver diseases caused by diabetes, obesity or cholesterol. 
Furthermore, the present study showed that, diabetic rat is associated with reduction in plasma total protein, 
albumin, globulin and conjugated bilirubin levels as well as elevation of total bilirubin and unconjugated bilirubin. 
According to Naganna (1989), an increase in total bilirubin indicates the abnormal liver function, possibly due to 
higher synthetic function of the liver. Alteration of protein metabolism could occur due to a reduced uptake of 
amino acids by tissues, an increased rate of muscle proteolysis (Ahmed, 2005) and a reduction in protein synthesis 
(Tragl and Reaven, 1972).The present study showed restoration of the altered levels of total protein, albumin, 
globulin, conjugated bilirubin, total bilirubin and unconjugated bilirubin in both CAFS supplementation and 
glibenclamide treated diabetic rats. Soon and Tan (2002) has also reported a reduction of plasma total protein level 
in STZ induced diabetic rats treated with Morinda officinalis. Low Albumin: Globulin (A/G) ratio has been 
reported to be associated with diabetes (Mandade and Sreenivas, 2011). A reduced plasma A/G ratio was observed 
in diabetic rats compared to normal control group. However, this effect was restored following the treatment with 
CAFS, which could be ascribed to the embedded phytonutrients that work synergistically or elicited a pathway 
that elevated the plasma A/G ratio. This result is in-line with the earlier report of Sundaram et al. (2009), who 
reported a restoration of the STZ-induced reduction of A/G ratio in diabetic rats treated with various plant extracts. 
The kidneys play a pivotal role in the regulation of electrolyte and acid–base balance. Urea and Creatinine 
are important markers of kidney function. Urea is the predominant nitrogen waste product of protein catabolism; 
as the rate of proteolysis increases, the production of urea by the liver increases. Creatinine is the major waste 
product of Creatine metabolism and excreted by the kidneys. In this study, diabetes induces elevation of the plasma 
urea and Creatinine concentrations. The observed elevation in urea and Creatinine levels signifies the increased 
proteolysis rate and decreased functional capacity of tubular excretion and suggesting impaired renal function. The 
observed improvement in the altered levels of urea and Creatinine of diabetic rats treated with CAFS 
supplementation similar to glibenclamide standard drug treated diabetic rats, suggests a protective role of CAFS 
on kidneys in diabetes caused kidney dysfunction. In agreement with these results, Latha and Daisy (2011) as well 
as Tanomand and Najafian (2013) reported the nephroprotective effect of gallic acid isolated from Terminali 
abellerica and cinnamon bark extract respectively against STZ- and gentamicin - induced kidney damage in 
experimental rats. 
Electrolyte imbalances are the early biochemical events responsible for long-term diabetic complications. 
Electrolyte imbalance occurs in diabetic patients from insulin deficiency, hyperglycemia and hyperketonemia 
(Kitabchi et al., 2006).  In uncontrolled diabetes, kidney function is compromised (Ikpi et al., 2009) with renal 
loss of electrolytes due to osmotic diueresis (Eteng et al., 2008).  This study observed reduction of plasma K+, Na+ 
and HCO3_ and on the contrary, elevation of Cl-concentrations in diabetic rats. The reduction of electrolytes in 
diabetes may be attributed to dehydration and renal loss of electrolytes by osmotic diueresis (Eteng et al., 2008). 
However, treatment of diabetic rats with CAFS supplementation reversed the altered levels of plasma K+, Na+, 
HCO3-and Cl- to near normal values, indicating the renal protective role of CAFS in diabetic rats. Our previous 
studies demonstrated that C. albidum fruit skin is a potent radical scavenging agent (Ibrahim et al., 2019a), 
hypolipidemic and hypoglycemic agents (Ibrahim et al., 2019b) and thus, suggests its protective role that could 
ameliorate the development of diabetic complications such as hepatopathy and nephropathy. 
 
Conclusion 
Liver and kidney damage are serious complications among patients with DM. This study demonstrated that in 
STZ-induced diabetic rats, CAFS could be effective in modulating the deleterious effects of chronic diabetes on 
the liver and kidney of experimental rats by maintaining the liver function enzymes activities and kidney function 
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markers concentrations toward normal values. CAFS supplementation at 70g/kg feed exhibited similar 
ameliorative potential with 2.5mg/kg bw glibenclamide (standard drug); hence, suggestive of its protective effects 
of the liver and kidneys. Thus, CAFS could be considered as therapeutic agent that can ameliorate the progression 
of diabetic complications. However, further research is required to elucidate the molecular mechanisms of the 
effects of CAFS.  
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